Cancer prevention : strategy for the futureDUBOIS, Raymond N.Carcinogenesis (New York. Print). 2006, Vol 27, Num 6, pp 1126-1127, issn 0143-3334, 2 p.Article

New paradigms for cancer preventionDUBOIS, Raymond N.Carcinogenesis (New York. Print). 2001, Vol 22, Num 5, pp 691-692, issn 0143-3334Article

Detection of differentially expressed genes in human colon carcinoma cells treated with a selective COX-2 inhibitorZHONGHUA ZHANG; DUBOIS, Raymond N.Oncogene (Basingstoke). 2001, Vol 20, Num 33, pp 4450-4456, issn 0950-9232Article

Role of cyclooxygenase inhibitors for the prevention of colorectal cancerSTACK, Elizabeth; DUBOIS, Raymond N.Gastroenterology clinics of North America. 2001, Vol 30, Num 4, issn 0889-8553, viii, 1001-1010 [10 p.]Article

Overview of the AACR Clinical and Translational Cancer Research Think Tank MeetingANDERSON, Kenneth C; DUBOIS, Raymond N.Clinical cancer research (Print). 2012, Vol 18, Num 3, pp 607-611, issn 1078-0432, 5 p.Article

Peroxisome proliferator-activated receptors modulate K-ras-mediated transformation of intestinal epithelial cellsJINYI SHAO; HONGMIAO SHENG; DUBOIS, Raymond N et al.Cancer research (Baltimore). 2002, Vol 62, Num 11, pp 3282-3288, issn 0008-5472Article

K-Ras-mediated increase in cyclooxygenase 2 mRNA stability involves activation of the protein kinase BHONGMIAO SHENG; JINYI SHAO; DUBOIS, Raymond N et al.Cancer research (Baltimore). 2001, Vol 61, Num 6, pp 2670-2675, issn 0008-5472Article

NSAIDs, eicosanoids, and the gastroenteric tractDUBOIS, Raymond N; GIARDIELLO, Francis M.Gastroenterology clinics of North America. 1996, Vol 25, Num 2, issn 0889-8553, 175 p.Serial Issue

COX-2 : A molecular target for colorectal cancer preventionBROWN, Joanne R; DUBOIS, Raymond N.Journal of clinical oncology. 2005, Vol 23, Num 12, pp 2840-2855, issn 0732-183X, 16 p.Article

Therapeutic Potential of Peroxisome Proliferator-Activated Receptors in Chronic Inflammation and Colorectal CancerDINGZHI WANG; DUBOIS, Raymond N.Gastroenterology clinics of North America. 2010, Vol 39, Num 3, issn 0889-8553, xi-xii, 697-707 [13 p.]Article

Cyclooxygenase-2: A potential target in breast cancerDINGZHI WANG; DUBOIS, Raymond N.Seminars in oncology. 2004, Vol 31, Num 1, pp 64-73, issn 0093-7754, 10 p., SUP3Article

Controversy: PPARγ as a target for treatment of colorectal cancerGUPTA, Rajnish A; DUBOIS, Raymond N.American journal of physiology. Gastrointestinal and liver physiology. 2002, Vol 46, Num 2, pp G266-G269, issn 0193-1857Article

COX-2 inhibition and colorectal cancerKOEHNE, Claus-Henning; DUBOIS, Raymond N.Seminars in oncology. 2004, Vol 31, Num 2, pp 12-21, issn 0093-7754, 10 p., SUP7Article

Cyclooxygenase-2 and Cancer Treatment: Understanding the Risk Should Be Worth the RewardMENTER, David G; SCHILSKY, Richard L; DUBOIS, Raymond N et al.Clinical cancer research (Print). 2010, Vol 16, Num 5, pp 1384-1390, issn 1078-0432, 7 p.Article

NSAIDs, gastrointestinal injury, and cytoprotectionSCHEIMAN, J. M.Gastroenterology clinics of North America. 1996, Vol 25, Num 2, issn 0889-8553, v, 279-298 [21 p.]Article

NSAID use and decreased risk of gastrointestinal cancersTHUN, M. J.Gastroenterology clinics of North America. 1996, Vol 25, Num 2, issn 0889-8553, vi, 333-348 [17 p.]Article

The role of COX-2 carcinogenesisDANNENBERG, Andrew J; DUBOIS, Raymond N; DUBINETT, Steven M et al.Seminars in oncology. 2004, Vol 31, Num 2, issn 0093-7754, 53 p., SUP7Serial Issue

Primary prevention: phytoprevention and chemoprevention of colorectal cancerTURINI, Marco E; DUBOIS, Raymond N.Hematology/oncology clinics of North America. 2002, Vol 16, Num 4, issn 0889-8588, v, 811-840 [30 p.]Article

Regulation of cyclo-oxygenase-2STACK, Elizabeth; DUBOIS, Raymond N.Baillière's best practice & research. Clinical gastroenterology. 2001, Vol 15, Num 5, pp 787-800, issn 1521-6918Article

Eicosanoids and inflammatory bowel diseaseYANG, V. W.Gastroenterology clinics of North America. 1996, Vol 25, Num 2, issn 0889-8553, vi, 317-332 [17 p.]Article

NSAID-induced polyp regression in familial adenomatous polyposis patientsGIARDIELLO, F. M.Gastroenterology clinics of North America. 1996, Vol 25, Num 2, issn 0889-8553, vi, 349-361 [14 p.]Article

CG100649, a novel COX-2 inhibitor, inhibits colorectal adenoma and carcinoma growth in mouse modelsKIM, Sun-Hee; MARGALIT, Ofer; KATOH, Hiroshi et al.Investigational new drugs. 2014, Vol 32, Num 6, pp 1105-1112, issn 0167-6997, 8 p.Article

Cyclooxygenase-1 is a potential target for prevention and treatment of ovarian epithelial cancerDAIKOKU, Takiko; DINGZHI WANG; TRANGUCH, Susanne et al.Cancer research (Baltimore). 2005, Vol 65, Num 9, pp 3735-3744, issn 0008-5472, 10 p.Article

Cyclooxygenase as a target in lung cancerBROWN, Joanne R; DUBOIS, Raymond N.Clinical cancer research. 2004, Vol 10, Num 12, pp 4266s-4269s, issn 1078-0432, 2Conference Paper

Kupffer cell-derived cyclooxygenase-2 regulates hepatocyte Bcl-2 expression in choledocho-venous fistula ratsSOUTO, Enrico O; MIYOSHI, Hideyuki; DUBOIS, Raymond N et al.American journal of physiology. Gastrointestinal and liver physiology. 2001, Vol 43, Num 5, pp G805-G811, issn 0193-1857Article